LP
Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
101
Galapagos
GLPG
$2.2B
|
FK
Faisal Khurshid
| $33.36 | $24 |
28%
downside
| Market Perform | 1 year ago |
|
102
Geron
GERN
$893M
|
FK
Faisal Khurshid
| $1.40 | $7 |
400%
upside
| Outperform | 1 year ago |
|
103
MannKind Corp
MNKD
$1.7B
|
FK
Faisal Khurshid
| $5.54 | $8 |
44%
upside
| Outperform | 1 year ago |
|
104
Vaxcyte
PCVX
$4.29B
|
DR
David Risinger
| $33.02 | $153 |
363%
upside
| Outperform | 1 year ago |
|
105
Penumbra
PEN
$11B
|
MK
Mike Kratky
| $281.46 | $263 |
7%
downside
| Outperform | 1 year ago |
|
106
Theravance Biopharma
TBPH
$703M
|
DR
David Risinger
| $13.95 | $10 |
28%
downside
| Market Perform | 1 year ago |
|
107
Waters Corp
WAT
$18.2B
|
PS
Puneet Souda
| $306.32 | $375 |
22%
upside
| Outperform | 1 year ago |
|
108
HCA Healthcare
HCA
$98.5B
| $420.77 | $396 |
6%
downside
| Outperform | 1 year ago |
|
|
109
Danaher
DHR
$143B
| $200.21 | $280 |
40%
upside
| Outperform | 1 year ago |
|
|
110
Ionis Pharmaceuticals
IONS
$9.76B
|
MF
Mani Foroohar
| $61.23 | $62 |
1%
upside
| Outperform | 1 year ago |
|
|
ALMS
111
Alumis Inc. Common Stock
ALMS
$469M
|
TS
Thomas Smith
| $4.51 | $29 |
543%
upside
| Outperform | 1 year ago |
|
112
Benitec Biopharma
BNTC
$365M
|
MF
Mani Foroohar
| $13.91 | $13 |
7%
downside
| Outperform | 1 year ago |
|
113
Lantheus
LNTH
$3.72B
| $54.75 | $127 |
132%
upside
| Outperform | 1 year ago |
|
|
114
Encompass Health
EHC
$12.6B
|
WM
Whit Mayo
| $125.58 | $100 |
20%
downside
| Outperform | 1 year ago |
|
115
Schrodinger
SDGR
$1.41B
|
MF
Mani Foroohar
| $19.13 | $29 |
52%
upside
| Outperform | 1 year ago |
|
116
Alnylam Pharmaceuticals
ALNY
$59.2B
| $452 | $159 |
65%
downside
| Market Perform | 1 year ago |
|
|
117
Sarepta Therapeutics
SRPT
$1.96B
|
MF
Mani Foroohar
| $18.71 | $230 |
1,129%
upside
| Outperform | 1 year ago |
|
118
Solid Biosciences
SLDB
$428M
|
JS
Joseph Schwartz
| $5.50 | $12 |
118%
upside
| Outperform | 1 year ago |
|
|
MREO
119
Mereo BioPharma
MREO
$282M
|
JS
Joseph Schwartz
| $1.77 | $8 |
352%
upside
| Outperform | 1 year ago |
|
120
Lexicon Pharmaceuticals
LXRX
$396M
| $1.09 | $5 |
359%
upside
| Outperform | 1 year ago |
|
|
121
Immunocore
IMCR
$1.87B
|
JC
Jonathan Chang
| $37.20 | $74 |
99%
upside
| Outperform | 1 year ago |
|
122
Xoma
XOMA
$426M
|
JZ
Jason Zhuang
| $35.24 | $40 |
14%
upside
| Outperform | 1 year ago |
|
123
CureVac
CVAC
$1.21B
|
MF
Mani Foroohar
| $5.39 | $4 |
26%
downside
| Market Perform | 1 year ago |
|
124
Tandem Diabetes Care
TNDM
$850M
|
MK
Mike Kratky
| $12.58 | $45 |
258%
upside
| Outperform | 1 year ago |
|
125
Cartesian Therapeutics
RNAC
$277M
|
TS
Thomas Smith
| $10.64 | $39 |
267%
upside
| Outperform | 1 year ago |
|